Induced pluripotent stem cells: A new era for hepatology

被引：54

作者：

Asgari, Samira ^{[1
,2
]}

Pournasr, Behshad ^{[1
]}

Salekdeh, Ghasem Hosseini ^{[3
,4
]}

Ghodsizadeh, Arefeh ^{[1
,2
]}

Ott, Michael ^{[5
,6
]}

Baharvand, Hossein ^{[1
,7
]}

机构：

[1] ACECR, Royal Inst Stem Cell Biol & Technol, Dept Stem Cells & Dev Biol, Tehran, Iran

[2] Univ Tehran, Coll Sci, Dept Biotechnol, Tehran, Iran

[3] ACECR, Royal Inst Stem Cell Biol & Technol, Dept Mol Syst Biol, Tehran, Iran

[4] Agr Biotechnol Res Inst Iran, Dept Syst Biol, Karaj, Iran

[5] Hannover Med Sch, Dept Gastroenterol Hepatol & Endocrinol, D-3000 Hannover, Germany

[6] Ctr Expt & Clin Infect Res, TWINCORE, Hannover, Germany

[7] Univ Sci & Culture, ACECR, Dept Dev Biol, Tehran, Iran

来源：

JOURNAL OF HEPATOLOGY | 2010年 / 53卷 / 04期

关键词：

Induced pluripotent stem (iPS) cells; Hepatology; Transplantation; Gene therapy; Bio-artificial livers; Drug development; HEPATOCYTE-LIKE CELLS; ORTHOTOPIC LIVER-TRANSPLANTATION; HIGHLY EFFICIENT DIFFERENTIATION; DENSITY-LIPOPROTEIN RECEPTOR; VIVO GENE-THERAPY; IPS CELLS; BIOARTIFICIAL LIVER; PHASE-I; DIRECTED DIFFERENTIATION; HEPATIC DIFFERENTIATION;

D O I：

10.1016/j.jhep.2010.05.009

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

Stem cell transplantation has been proposed as an attractive alternative approach to restore liver mass and function. Recent progress has been reported on the generation of induced pluripotent stem (iPS) cells from somatic cells. Human-iPS cells can be differentiated towards the hepatic lineage which presents possibilities for improving research on diseases, drug development, tissue engineering, the development of bio-artificial livers, and a foundation for producing autologous cell therapies that would avoid immune rejection and enable correction of gene defects prior to cell transplantation. This focused review will discuss how human iPS cell advances are likely to have an impact on hepatology. (C) 2010 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.

引用

页码：738 / 751

页数：14

共 50 条

[31] Induced pluripotent stem cells
A. I. Shevchenko
S. P. Medvedev
N. A. Mazurok
S. M. Zakian
Russian Journal of Genetics, 2009, 45 : 139 - 146
[32] Induced pluripotent stem cells from adult testis: a new source of stem cells?
Skutella, Thomas
REGENERATIVE MEDICINE, 2009, 4 (01) : 3 - 5
[33] Embryonic Stem Cells and Induced Pluripotent Stem Cells
Avcilar, Huseyin
Saraymen, Berkay
Ozturan, Okan Ozgur
Koker, Mustafa Yavuz
ASTIM ALLERJI IMMUNOLOJI, 2018, 16 (01): : 1 - 10
[34] Induced pluripotent stem cells: a new revolution for clinical neurology?
Mattis, Virginia B.
Svendsen, Clive N.
LANCET NEUROLOGY, 2011, 10 (04): : 383 - 394
[35] Induced pluripotent stem cells: A new addition to the virologists armamentarium
Kuadkitkan, Atichat
Wikan, Nitwara
Smith, Duncan R.
JOURNAL OF VIROLOGICAL METHODS, 2016, 235 : 191 - 195
[36] Induced Pluripotent Stem Cells: A New Approach for Physiological Research
Pfannkuche, Kurt
Hannes, Tobias
Khalil, Markus
Noghabi, Monireh Soroush
Morshedi, Amir
Hescheler, Juergen
Droege, Peter
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2010, 26 (02) : 105 - 124
[37] Human Induced Pluripotent Stem Cells: A New Model for Schizophrenia?
Buxbaum, Joseph D.
Sklar, Pamela
CELL STEM CELL, 2011, 8 (05) : 461 - 462
[38] A New Dimension of Clinical Pharmacology: Induced Pluripotent Stem Cells
Ito, S.
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2011, 89 (05) : 629 - 632
[39] Induced pluripotent stem cells: a new tool for toxicology screening?
Heng, Boon Chin
Richards, Mark
Shu, Yimin
Gribbon, Philip
ARCHIVES OF TOXICOLOGY, 2009, 83 (07) : 641 - 644
[40] Induced pluripotent stem cells: a new tool for toxicology screening?
Boon Chin Heng
Mark Richards
Yimin Shu
Philip Gribbon
Archives of Toxicology, 2009, 83 : 641 - 644

← 1 2 3 4 5 →